ecteinascidin 743 has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allavena, P; Anichini, A; Anselmo, A; Belgiovine, C; Beltrame, L; Casali, PG; D'Incalci, M; Erba, E; Frapolli, R; Fuso Nerini, I; Galmarini, CM; Germano, G; Liguori, M; Mantovani, A; Marchini, S; Mortarini, R; Nebuloni, M; Pasqualini, F; Pesce, S; Pilotti, S; Sanfilippo, R; Uboldi, S; van Rooijen, N; Zucchetti, M | 1 |
1 other study(ies) available for ecteinascidin 743 and Carcinoma, Lewis Lung
Article | Year |
---|---|
Role of macrophage targeting in the antitumor activity of trabectedin.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Caspase 8; Cell Proliferation; Dioxoles; Female; Fibrosarcoma; Flow Cytometry; Humans; Immunoenzyme Techniques; Macrophages; Mice; Monocytes; Myeloid Cells; Neovascularization, Pathologic; Ovarian Neoplasms; Phagocytes; Signal Transduction; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2013 |